Kezar Life Sciences, Inc. (KZR)
NASDAQ
Market Cap
$45.94M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
425 of 809
Rank in Industry
243 of 445
Largest Insider Buys in Sector
KZR Stock Price History Chart
KZR Stock Performance
About Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.
Insider Activity of Kezar Life Sciences, Inc.
Over the last 12 months, insiders at Kezar Life Sciences, Inc. have bought $0 and sold $0 worth of Kezar Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Kezar Life Sciences, Inc. have bought $9.69M and sold $1.96M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $295,400 was made by BERGER FRANKLIN M () on 2022‑03‑18.
List of Insider Buy and Sell Transactions, Kezar Life Sciences, Inc.
| 2023-02-06 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.88 | $275,320 | -69.99% | |
| 2023-02-03 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 25,000 0.0348% | $7.15 | $178,650 | -70.28% | |
| 2023-02-02 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 50,000 0.0681% | $7.19 | $359,500 | -71.00% | |
| 2023-02-01 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.95 | $278,000 | -68.99% | |
| 2023-01-31 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $7.08 | $212,400 | -69.73% | |
| 2023-01-30 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $6.91 | $207,300 | -68.71% | |
| 2023-01-25 | Sale | Morningside Venture Investments Ltd | director | 50,000 0.0697% | $6.85 | $342,500 | -67.24% | |
| 2023-01-24 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1103% | $6.98 | $558,400 | -68.08% | |
| 2023-01-23 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1109% | $6.81 | $544,800 | -66.76% | |
| 2023-01-17 | Sale | Morningside Venture Investments Ltd | director | 6,114 0.0088% | $6.79 | $41,514 | -64.10% | |
| 2023-01-13 | Sale | Morningside Venture Investments Ltd | director | 1,971 0.0029% | $7.15 | $14,093 | -65.50% | |
| 2023-01-12 | Sale | Morningside Venture Investments Ltd | director | 5,000 0.0068% | $6.77 | $33,850 | -65.80% | |
| 2023-01-06 | Sale | Morningside Venture Investments Ltd | director | 3,000 0.0042% | $6.89 | $20,670 | -65.20% | |
| 2023-01-05 | Sale | Morningside Venture Investments Ltd | director | 12,162 0.017% | $6.97 | $84,769 | -65.51% | |
| 2023-01-04 | Sale | Morningside Venture Investments Ltd | director | 30,000 0.0414% | $7.17 | $215,100 | -66.90% | |
| 2023-01-03 | Sale | Morningside Venture Investments Ltd | director | 500 0.0007% | $7.10 | $3,550 | -65.66% | |
| 2022-12-29 | Sale | Morningside Venture Investments Ltd | director | 25,000 0.0375% | $7.10 | $177,500 | -66.07% | |
| 2022-10-04 | Sale | Morningside Venture Investments Ltd | director | 3,612 0.0056% | $8.82 | $31,857 | ||
| 2022-10-03 | Sale | Morningside Venture Investments Ltd | director | 28,700 0.0425% | $8.78 | $251,957 | ||
| 2022-03-18 | BERGER FRANKLIN M | 20,000 0.0313% | $14.77 | $295,400 | -52.05% |
Insider Historical Profitability
10.68%
| Equal Talent Investments Ltd | 10 percent owner | 6254545 8.5914% | $0.63 | 1 | 0 | +13.64% |
| Morningside Venture Investments Ltd | 10 percent owner | 5447993 7.4835% | $0.63 | 2 | 19 | +42.12% |
| Cormorant Asset Management, LP | 10 percent owner | 1572909 2.1606% | $0.63 | 1 | 0 | +15.16% |
| BERGER FRANKLIN M | 890691 1.2235% | $0.63 | 4 | 0 | +11.46% | |
| BAY CITY CAPITAL LLC | 10 percent owner | 622229 0.8547% | $0.63 | 1 | 0 | +15.16% |
| Kirk Christopher J. | President and CSO | 342609 0.4706% | $0.63 | 3 | 0 | +11.51% |
| Kauffman Michael | director | 63690 0.0875% | $0.63 | 0 | 1 | |
| Fowler John Franklin | CEO | 38461 0.0528% | $0.63 | 4 | 0 | +19% |
| Belsky Marc | CFO | 15384 0.0211% | $0.63 | 6 | 0 | +9.02% |
| Economides Vassiliki | SVP, Strategy & External Aff. | 7570 0.0104% | $0.63 | 5 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Suvretta Capital Management, LLC | $6.46M | 9.85 | 7.17M | 0% | +$0 | 0.27 | |
| Avidity Partners Management Lp | $4.53M | 6.9 | 5.03M | +0.01% | +$492.27 | 0.16 | |
| BlackRock | $4.16M | 6.34 | 4.62M | -4.16% | -$180,570.67 | <0.0001 | |
| The Vanguard Group | $2.79M | 4.25 | 3.09M | +1% | +$27,715.19 | <0.0001 | |
| Sphera Fund | $1.85M | 2.82 | 2.05M | 0% | +$0 | 0.31 | |
| OrbiMed | $1.74M | 2.65 | 1.93M | 0% | +$0 | 0.04 | |
| Acadian Asset Management | $1.61M | 2.46 | 1.79M | +42.51% | +$481,154.32 | 0.01 | |
| Affinity Asset Advisors | $1.59M | 2.42 | 1.76M | New | +$1.59M | 0.28 | |
| Geode Capital Management | $1.24M | 1.89 | 1.37M | +1.41% | +$17,169.10 | <0.0001 | |
| Renaissance Technologies | $1.21M | 1.84 | 1.34M | +3.57% | +$41,599.29 | <0.01 | |
| Two Sigma | $1.17M | 1.79 | 1.3M | +7.07% | +$77,543.90 | <0.01 | |
| Two Sigma Advisers LP | $1.11M | 1.69 | 1.23M | -6.84% | -$81,594.81 | <0.01 | |
| State Street | $1.01M | 1.54 | 1.12M | +0.69% | +$6,962.16 | <0.0001 | |
| Prosight Management Lp | $868,780.00 | 1.32 | 963,598 | -71.37% | -$2.17M | 0.24 | |
| Ikarian Capital LLC | $783,484.00 | 1.19 | 868,992 | +1.83% | +$14,065.88 | 0.22 | |
| Qiming U S Ventures Management Llc | $747,166.00 | 1.14 | 828,711 | 0% | +$0 | 0.83 | |
| Millennium Management LLC | $736,583.00 | 1.12 | 816,973 | -72.09% | -$1.9M | <0.01 | |
| Acuitas Investments, LLC | $622,851.00 | 0.95 | 690,829 | New | +$622,851.00 | 0.33 | |
| Tang Capital Management, LLC | $621,151.00 | 0.95 | 688,943 | +124.66% | +$344,661.84 | <0.01 | |
| Northern Trust | $464,651.00 | 0.71 | 515,363 | -5.17% | -$25,337.65 | <0.0001 | |
| Citadel Advisors LLC | $459,423.00 | 0.7 | 509,564 | +39.48% | +$130,042.30 | <0.0001 | |
| D. E. Shaw & Co. | $378,153.00 | 0.58 | 419,425 | +11.26% | +$38,271.96 | <0.01 | |
| Goldman Sachs | $364,883.00 | 0.56 | 404,706 | -8.59% | -$34,274.33 | <0.0001 | |
| Schroder Investment Management Group | $315,915.00 | 0.48 | 350,394 | 0% | +$0 | <0.0001 | |
| Nuveen | $283,789.00 | 0.43 | 314,762 | 0% | +$0 | <0.0001 | |
| Gsa Capital Partners Llp | $255,000.00 | 0.39 | 282,595 | +8.52% | +$20,021.37 | 0.02 | |
| Deutsche Bank | $251,339.00 | 0.38 | 279,265 | 0% | +$0 | <0.0001 | |
| Panagora | $210,259.00 | 0.32 | 233,206 | +177.34% | +$134,445.99 | <0.01 | |
| Charles Schwab | $204,203.00 | 0.31 | 226,490 | 0% | +$0 | <0.0001 | |
| BNY Mellon | $193,181.00 | 0.29 | 214,264 | -3.58% | -$7,170.45 | <0.0001 | |
| Boothbay Fund Management LLC | $135,677.00 | 0.21 | 150,485 | +11.57% | +$14,065.83 | 0.01 | |
| Tealwood Asset Management | $113,688.00 | 0.17 | 126,095 | New | +$113,688.00 | 0.03 | |
| RhumbLine Advisers | $98,701.00 | 0.15 | 109,435 | +2.41% | +$2,326.94 | <0.0001 | |
| Bridgeway Capital Management | $97,914.00 | 0.15 | 108,600 | -31.53% | -$45,080.11 | <0.01 | |
| Morgan Stanley | $91,198.00 | 0.14 | 101,151 | -60.99% | -$142,572.21 | <0.0001 | |
| Prelude Capital | $90,882.00 | 0.14 | 100,801 | New | +$90,882.00 | 0.01 | |
| Wells Fargo | $80,873.00 | 0.12 | 89,700 | -6.38% | -$5,513.25 | <0.0001 | |
| Amundi | $64,775.00 | 0.11 | 82,243 | 0% | +$0 | <0.0001 | |
| AllianceBernstein | $71,279.00 | 0.11 | 79,058 | 0% | +$0 | <0.0001 | |
| UBS | $64,501.00 | 0.1 | 71,509 | +45.42% | +$20,146.13 | <0.0001 | |
| Susquehanna International Group | $48,070.00 | 0.07 | 53,316 | -37.57% | -$28,933.42 | <0.0001 | |
| Jacobs Levy Equity Management | $47,980.00 | 0.07 | 53,216 | -94.52% | -$827,333.13 | <0.0001 | |
| Barclays | $45,000.00 | 0.07 | 50,118 | -48.88% | -$43,025.56 | <0.0001 | |
| T. Rowe Price | $43,000.00 | 0.07 | 47,674 | +2.86% | +$1,196.90 | <0.0001 | |
| American International Group | $31,711.00 | 0.05 | 35,172 | -0.85% | -$271.38 | <0.0001 | |
| Bank of America | $29,958.00 | 0.05 | 33,249 | -62.74% | -$50,449.89 | <0.0001 | |
| Occudo Quantitative Strategies Lp | $28,643.00 | 0.04 | 31,769 | -7.36% | -$2,276.55 | 0.01 | |
| JPMorgan Chase | $27,466.00 | 0.04 | 30,464 | -34.15% | -$14,240.59 | <0.0001 | |
| Ironwood Investment Management Llc | $25,256.00 | 0.04 | 28,012 | +11.39% | +$2,582.22 | 0.01 | |
| Fidelis Capital Partners Llc | $24,583.00 | 0.04 | 27,266 | New | +$24,583.00 | <0.01 |